The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnpario Regulatory News (ANP)

Share Price Information for Anpario (ANP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 255.00
Bid: 250.00
Ask: 260.00
Change: 0.00 (0.00%)
Spread: 10.00 (4.00%)
Open: 255.00
High: 255.00
Low: 255.00
Prev. Close: 255.00
ANP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Tender Offer

23 Jun 2023 07:00

RNS Number : 6642D
Anpario PLC
23 June 2023
 

23 June 2023

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF THAT JURISDICTION.

 

Anpario plc

("Anpario" or the "Company")

 

Result of Tender Offer

Total Voting Rights

and

Directors' interests

 

 

Anpario (AIM: ANP), the independent manufacturer of natural sustainable animal feed additives for health, nutrition and biosecurity, is pleased to announce the result of its Tender Offer, details of which were set out in the circular published by the Company on 2 June 2023 (the "Circular").

 

The maximum aggregate number of Ordinary Shares that could be purchased pursuant to the Tender Offer was 4,000,000 Ordinary Shares at the Tender Price of 225 pence per Ordinary Share, for an aggregate maximum consideration of £9.0 million. The Tender Offer closed at 1.00 p.m. on 22 June 2023. Valid tenders were received in respect of 4,288,700 Ordinary Shares, equal to approximately 107 per cent of the total number of Ordinary Shares subject to the Tender Offer.

 

As the Tender Offer was oversubscribed by 288,700 Ordinary Shares, not all of the Ordinary Shares that have been validly tendered have been accepted and purchased. The Guaranteed Entitlement therefore applies to each Qualifying Shareholder. Tenders have been accepted on the basis set out in paragraphs 2.14.1 and 2.14.2 of Part IV of the Circular:

 

· all Ordinary Shares validly tendered up to the Guaranteed Entitlement, for each relevant holding of Ordinary Shares, will be accepted and purchased in full; and

 

· all Ordinary Shares validly tendered in excess of the Guaranteed Entitlement and up to the Excess Entitlement, for each relevant holding of Ordinary Shares, will be scaled down pro rata to the total number of such Ordinary Shares tendered in excess of the Guaranteed Entitlement and up to the Excess Entitlement such that the total cost of Ordinary Shares to be purchased pursuant to the Tender Offer does not exceed £9 million, provided, however, that the Company shall be entitled to exercise its discretion to adjust such scaling down on the basis that the removal of any Shareholders in full from the register of members would bring administrative cost saving to the Company and in recognition that Shareholders may not wish to hold small and uneconomic numbers of Ordinary Shares.

 

Of the total number of Ordinary Shares validly tendered and purchased by the Company, all 4,000,000 Ordinary Shares will be cancelled, with effect from on or around 7 July 2023. The Company also intends to cancel all other Ordinary Shares held in treasury (440,388 Ordinary Shares) at the same time.

 

CREST accounts will be credited for revised uncertificated holdings of Ordinary Shares and Tender Offer proceeds by 7 July 2023. For Ordinary Shares held in certificated form, cheques in respect of Tender Offer proceeds and balancing share certificates will be despatched by 7 July 2023.

 

Total Voting Rights

Following the closing of the Tender Offer and the cancellation of 4,440,388 Ordinary Shares referred to above, the Company will have 20,063,131 Ordinary Shares in issue with no Ordinary Shares held in treasury. Therefore, the total number of voting rights in the Company will be 20,063,131 which may be used by Shareholders as the denominator in the calculations by which they may determine if they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Directors' interests

 

As set out in the Circular, the Company received irrevocable undertakings from each of the Directors (with the exception of Kate Allum who is not a Shareholder) that they would each not participate in the Tender Offer in respect of any Ordinary Shares of which they are the registered or beneficial holder, or otherwise hold on trust as trustees (as applicable). Therefore, following cancellation of the successfully tendered Ordinary Shares and Ordinary Shares currently held in treasury ("Cancellation"), the interests of each Director, of the Company's total voting rights will be follows:

 

Name

Number of Ordinary Shares held pre and post Cancellation

% of Company's total voting rights immediately following Cancellation

Richard Edwards

203,396

1.01%

Karen Prior

157,445

0.78%

Marc Wilson

14,951

0.07%

Matthew Robinson

8,600

0.04%

Total

384,392

1.92%

 

Capitalised terms used in this announcement (unless otherwise defined) have the meanings set out in the Circular.

 

The information communicated in this announcement contains inside information for the purposes of Article 7 of the UK version of the EU Market Abuse Regulation (2014/596) which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended and supplemented from time to time.

 

The person responsible for arranging the release of this announcement on behalf of the Company is Richard Edwards, CEO.

 

 

Enquiries:-

 

Anpario plc:

 

 

Richard Edwards, CEO

+44(0)7776 417 129

Marc Wilson, Group Finance Director

+44(0)1909 537 380

Shore Capital:

(Nominated Adviser and Broker):

+44 (0) 20 7408 4090

Stephane Auton

David Coaten

Corporate Advisory

 

Tom Knibbs

 

Henry Willcocks

Corporate Broking

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RTESEAEFEEDSEEM
Date   Source Headline
21st Mar 202411:37 amRNSDirector/PDMR Shareholding
21st Mar 20247:00 amRNSDirector/PDMR Shareholding
5th Feb 20247:00 amRNSAward of Options and Director/PDMR Shareholding
24th Jan 20247:00 amRNSFull year trading statement
17th Jan 20247:00 amRNSBlock listing Interim Review
5th Oct 20239:23 amRNSDirector Disclosure
13th Sep 20237:00 amRNSHalf-year Report
25th Aug 20235:10 pmRNSBlock listing Interim Review
1st Aug 20237:00 amRNSDirectorate Change
10th Jul 20232:14 pmRNSHolding(s) in Company
7th Jul 20232:34 pmRNSHolding(s) in Company
29th Jun 20233:57 pmRNSResult of AGM
29th Jun 20237:00 amRNSAGM Statement
23rd Jun 20237:00 amRNSResult of Tender Offer
19th Jun 20232:48 pmRNSGM Statement
15th Jun 20237:00 amRNSShareholder Tour
7th Jun 20234:09 pmRNSReplacement - Tender Offer
6th Jun 20237:00 amRNSPosting of Annual Report and Notice of AGM
2nd Jun 20237:00 amRNSTender Offer
23rd May 20237:00 amRNSChange of Adviser
19th May 20234:40 pmRNSDirector Disclosures
19th May 20233:35 pmRNSTotal Voting Rights
5th May 20237:00 amRNSDirectorate Change
21st Apr 20237:00 amRNSAnpario receives King’s Award for Enterprise
11th Apr 20237:00 amRNSDirector/PDMR Shareholding
31st Mar 20231:13 pmRNSHolding(s) in Company
28th Mar 20237:00 amRNSDirector/PDMR Shareholding
22nd Mar 20237:00 amRNSFinal Results
3rd Feb 20237:00 amRNSDirector/PDMR Shareholding
24th Jan 202312:56 pmRNSBlock listing Interim Review
9th Jan 20237:00 amRNSFull Year Trading Statement
16th Dec 20227:00 amRNSAnpario receives ISO 14001 Certification
4th Nov 202212:52 pmRNSTotal Voting Rights
19th Oct 20227:00 amRNSDirector/PDMR Shareholding - Replacement
18th Oct 20227:00 amRNSDirector/PDMR Shareholding
6th Oct 20227:00 amRNSESG Initiatives
3rd Oct 20222:32 pmRNSDirector/PDMR Shareholding
14th Sep 20227:00 amRNSHalf-year Report
5th Sep 202212:38 pmRNSTotal Voting Rights
5th Aug 20222:00 pmRNSBob The Pigeon Back Home in Gateshead, Pet!
20th Jul 20221:02 pmRNSBlock listing Interim Review
7th Jul 20222:59 pmRNSHolding(s) in Company
22nd Jun 202211:24 amRNSAGM Statement
16th Jun 20226:00 pmRNSResult of AGM
16th Jun 20227:00 amRNSAGM Statement
27th May 202212:56 pmRNSHolding(s) in Company
24th May 20221:10 pmRNSHolding(s) in Company
11th May 20227:00 amRNSNotice of AGM
10th May 20223:55 pmRNSHolding(s) in Company
5th May 20223:18 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.